An RNA-based survival model predicting real-world response to trastuzumab deruxtecan
Antibody-drug conjugates (ADCs) like trastuzumab deruxtecan (T-DXd, Enhertu) have [...]
The rhythm and dissonance of cancer biology | TPM podcast #54
Upcoming events Genialis on LinkedIn [...]
Visual analytics framework for survival analysis and biomarker discovery from gene expression data
We introduce a visual analytics methodology for survival analysis, [...]
Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53
Upcoming events Genialis on LinkedIn [...]
Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
Genialis Expressions empowers drug development teams to make confident [...]
When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52
Get in touch TPM podcast archive [...]
Frequency of driver mutations across disease stages in Slovenian non-small cell lung cancer patients
This poster presents the first comprehensive analysis of actionable [...]
From platform to portfolio: Using AI to derisk gene therapy and genetic medicine | TPM podcast #51
ESMO AI 2025 poster TPM podcast [...]
A large molecular model (LMM)-based predictor of clinical response to the WEE1 inhibitor Debio 0123 + carboplatin therapy
DNA Damage Response (DDR) dysregulation is a major factor [...]
Real world data and artificial intelligence turn anecdote to evidence | TPM podcast #50
TPM podcast archive Genialis on LinkedIn [...]
